336 related articles for article (PubMed ID: 27297729)
1. Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis.
Hakami NY; Dusting GJ; Peshavariya HM
J Cell Mol Med; 2016 Oct; 20(10):1932-44. PubMed ID: 27297729
[TBL] [Abstract][Full Text] [Related]
2. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis.
Kim YM; Kim SJ; Tatsunami R; Yamamura H; Fukai T; Ushio-Fukai M
Am J Physiol Cell Physiol; 2017 Jun; 312(6):C749-C764. PubMed ID: 28424170
[TBL] [Abstract][Full Text] [Related]
3. Both hydrogen peroxide and transforming growth factor beta 1 contribute to endothelial Nox4 mediated angiogenesis in endothelial Nox4 transgenic mouse lines.
Chen L; Xiao J; Kuroda J; Ago T; Sadoshima J; Cohen RA; Tong X
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2489-99. PubMed ID: 25315297
[TBL] [Abstract][Full Text] [Related]
4. NOX2, NOX4, and mitochondrial-derived reactive oxygen species contribute to angiopoietin-1 signaling and angiogenic responses in endothelial cells.
Harel S; Mayaki D; Sanchez V; Hussain SNA
Vascul Pharmacol; 2017 May; 92():22-32. PubMed ID: 28351775
[TBL] [Abstract][Full Text] [Related]
5. Transforming Growth Factor β1-Induced NADPH Oxidase-4 Expression and Fibrotic Response in Conjunctival Fibroblasts.
Brown KD; Shah MH; Liu GS; Chan EC; Crowston JG; Peshavariya HM
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3011-3017. PubMed ID: 28605812
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis.
Rössig L; Li H; Fisslthaler B; Urbich C; Fleming I; Förstermann U; Zeiher AM; Dimmeler S
Circ Res; 2002 Nov; 91(9):837-44. PubMed ID: 12411399
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
[TBL] [Abstract][Full Text] [Related]
9. CYLD Deubiquitinates Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4 Contributing to Adventitial Remodeling.
Yu B; Liu Z; Fu Y; Wang Y; Zhang L; Cai Z; Yu F; Wang X; Zhou J; Kong W
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1698-1709. PubMed ID: 28751569
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Oxidative Stress in Pulmonary Artery Endothelium. Modulation of Extracellular Superoxide Dismutase and NOX4 Expression Using Histone Deacetylase Class I Inhibitors.
Zelko IN; Folz RJ
Am J Respir Cell Mol Biol; 2015 Oct; 53(4):513-24. PubMed ID: 25749103
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β1 requires NADPH oxidase 4 for angiogenesis in vitro and in vivo.
Peshavariya HM; Chan EC; Liu GS; Jiang F; Dusting GJ
J Cell Mol Med; 2014 Jun; 18(6):1172-83. PubMed ID: 24629065
[TBL] [Abstract][Full Text] [Related]
12. Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis.
Peshavariya HM; Liu GS; Chang CW; Jiang F; Chan EC; Dusting GJ
Antioxid Redox Signal; 2014 Jun; 20(17):2710-25. PubMed ID: 24450852
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
Kaimori A; Potter JJ; Choti M; Ding Z; Mezey E; Koteish AA
Hepatology; 2010 Sep; 52(3):1033-45. PubMed ID: 20564330
[TBL] [Abstract][Full Text] [Related]
14. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms.
Di Bartolo BA; Cartland SP; Prado-Lourenco L; Griffith TS; Gentile C; Ravindran J; Azahri NS; Thai T; Yeung AW; Thomas SR; Kavurma MM
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26572549
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin attenuates oxidized low-density lipoprotein induced oxidative stress in human umbilical vein endothelial cells by reducing NADPH oxidase activity.
Chen B; Meng L; Shen T; Gong H; Qi R; Zhao Y; Sun J; Bao L; Zhao G
Biochem Biophys Res Commun; 2017 Sep; 490(4):1326-1333. PubMed ID: 28688762
[TBL] [Abstract][Full Text] [Related]
16. NADPH oxidase 4-derived H2O2 promotes aberrant retinal neovascularization via activation of VEGF receptor 2 pathway in oxygen-induced retinopathy.
Li J; Wang JJ; Zhang SX
J Diabetes Res; 2015; 2015():963289. PubMed ID: 25866826
[TBL] [Abstract][Full Text] [Related]
17. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.
Schröder K; Zhang M; Benkhoff S; Mieth A; Pliquett R; Kosowski J; Kruse C; Luedike P; Michaelis UR; Weissmann N; Dimmeler S; Shah AM; Brandes RP
Circ Res; 2012 Apr; 110(9):1217-25. PubMed ID: 22456182
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of suberoylanilide hydroxamic acid on angiogenesis and its molecular mechanism].
Wang N; Chen L; Zhang L; Jiang R; Chen L; Shen Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):266-9, 273. PubMed ID: 24606744
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.
Deroanne CF; Bonjean K; Servotte S; Devy L; Colige A; Clausse N; Blacher S; Verdin E; Foidart JM; Nusgens BV; Castronovo V
Oncogene; 2002 Jan; 21(3):427-36. PubMed ID: 11821955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
